Amide derivatives as gk activators
CA 2471049 A1 · Owner: Lau, Jesper · Inventors: Mjalli, Adnan M. M.; Lau, Jesper; Kodra, Janos Tibor
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to compounds of the general formula (I) which are activators of glucokinase (GK), and which may be useful for the management treatment, control, or adjunct treatment of diseases or conditions where , increasing glucokinase activity is beneficial for example diseases such as , IGT, Syndrome X type 2 diabetes, type 1 diabetes, dyslipidemia hyperlipidemia, hypertension, and obesity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 19, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 19, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 19, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.